Clinical trials
Neonatal Infection clinical trials
Below are recruiting neonatal infection clinical trials, each written for real people, not researchers. We’re tracking 28 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06824350Recruiting
Chlorine in water to prevent newborn infections
This trial tests whether adding a small amount of chlorine to the drinking water at public health facilities can reduce infections (including those resistant to antibiotics) in newborns. You and your baby may be eligible if you deliver at a participating facility that does not already chlorinate its water.
Berkeley, CaliforniaAges Any age - NCT05742490Recruiting
Track infections in newborns to improve care
This study collects information about newborns in participating hospital units who have an infection confirmed by a lab test. The goal is to better understand infection patterns so care for newborns can improve.
LondonAges 1 minute–1 year - NCT07190560Recruiting
Study of a treatment for newborns exposed to chikungunya
This trial tests a new treatment (PC-CHIK-V) for newborns whose mothers had chikungunya around the time of birth. The goal is to see if the treatment can prevent or reduce the infection in babies. Babies who are not treated will also be followed for comparison.
Saint-PierreAges birth–2 days - NCT07109856Recruiting
A new tool to predict infection in newborns
This study tests a simple non-invasive score that uses blood flow in muscles to predict if a newborn has or will develop high inflammation levels (C-reactive protein). It may help doctors start treatment earlier in babies with breathing problems.
Graz, StyriaAges birth–6 hours - NCT06973174Recruiting
B. cereus infections in premature newborns
This study looks at a type of bacterial infection (Bacillus cereus) that can affect the blood or brain lining in premature babies. It helps doctors learn more about these infections so they can improve care.
Nice, Alpes MaritimesAges Up to 5 months - NCT07635368Recruiting
Blood Markers in Newborns With CMV Infection
This research study examines blood samples from newborns to identify biological markers (proteins and genetic signals) that could help detect and understand congenital cytomegalovirus (CMV) infection—a virus some babies are born with. Finding these markers might help doctors identify infected infants earlier and develop better treatments.
CopenhagenAges birth–4 weeks - NCT04818762Recruiting
Measuring oxygen use in newborns with breathing trouble
This study looks at how well oxygen is being used by the body in newborns who are having breathing problems, from birth through the first hours of life. It also studies whether infection plays a role, which may help doctors better understand and treat newborn breathing trouble.
Graz, StyriaAges Up to 6 hours - NCT06656104Recruiting
Multi-infusion strategy effect on bloodstream infections in premature babies
This trial tests whether a special method of giving multiple IV medicines at the same time can reduce serious bloodstream infections in premature babies. The study focuses on very small and early-born infants who need several infusions.
Bron, FranceAges Up to 7 months - NCT02096536RecruitingPhase 4
Studying how vancomycin is handled in newborns
This study looks at how the antibiotic vancomycin moves through and acts in newborn babies. It may help doctors dose the medicine more safely and effectively for babies in intensive care.
Leuven, Vlaams-BrabantAges 1 day–1.9 years - NCT06102044RecruitingPhase 3
Zinc for young infants with severe infection in Tanzania
This study tests whether giving zinc supplements to very young babies (under 2 months) with severe infections helps them recover better. It takes place in Tanzania and involves adding zinc to their regular care.
Dar es SalaamAges birth–2 months - NCT06058819Recruiting
New blood test to guide antibiotic use in newborns
This study is testing a new blood test to see if it can help doctors decide when to use antibiotics for newborns who may have a late-onset infection. The goal is to reduce unnecessary antibiotic use.
BronAges 1 week–2 weeks - NCT06283355RecruitingPhase 1
Comparing one vs. multiple nasal treatments in NICU babies
This study tests whether giving one versus multiple doses of a special nasal treatment (called nasal microbiota therapy, or NMT) changes the types of helpful bacteria in your baby's nose. The goal is to see if the treatment keeps bad bacteria, like staph, from growing.
Baltimore, MarylandAges birth–60 years - NCT07335874Recruiting
Hearing screening follow-up for congenital infection in newborns
This study checks if babies who fail their newborn hearing test might have a hidden infection from birth. It looks for cytomegalovirus (CMV), a common virus that can affect hearing, using a simple test.
StrasbourgAges birth–1 month - NCT05813184Recruiting
Prenatal antibiotics and breast milk effects on newborn immunity
This study looks at how taking antibiotics during late pregnancy affects a baby’s early immune protection, with breastfeeding as an important factor. You may be able to join if you plan to breastfeed and either received antibiotics for at least 7 days after 32 weeks or did not receive such antibiotics during pregnancy.
MilanAges 18–40 - NCT04664569Recruiting
Study of treatments for bacterial meningitis in children
This study enrolls children and newborns with suspected or confirmed bacterial meningitis. The goal is to understand and improve care for serious infections that affect the lining around the brain.
CréteilAges 1 day–18 years - NCT06018792Recruiting
New blood test for faster sepsis diagnosis in children
This trial tests a new, faster way to find bacteria in the blood of children with suspected sepsis. It uses a molecular test that may give results sooner than standard cultures, helping doctors treat infections more quickly.
AmsterdamAges birth–18 years - NCT07421323Recruiting
Hand cleaning study for premature babies in the NICU
This study tests if a special hand-cleaning method using chlorhexidine and alcohol can help prevent infections in premature babies (born before 37 weeks) in the newborn intensive care unit (NICU). It aims to see if this cleaning approach is better than the usual method for keeping babies safe from hospital-acquired infections.
AlexandriaAges 6 hours–1 day - NCT07356583Recruiting
Neonatal enterovirus infections in Italy
This study looks at enterovirus infections in newborn babies admitted to intensive care, focusing on one type called echovirus 11. It aims to better understand the virus and how it affects babies to improve care.
Pavia, LombardyAges 1 day–4 weeks - NCT05564598RecruitingPhase 2
Trial of immune therapy for newborns with congenital CMV
This Phase 2 trial tests an immune treatment made from donor T-cells to help the body fight congenital CMV infection in newborns. It may be an option if your baby is very young, has evidence of CMV infection, and meets specific blood, kidney, and liver safety limits.
Los Angeles, CaliforniaAges birth–3 weeks - NCT00747851Recruiting
Study of immune signals in newborns with early inflammation or infection
This study looks at how immune-related “NETs” might protect or possibly harm newborn babies during early inflammation or infection. It may help doctors understand which immune responses are helpful versus risky in the NICU.
Salt Lake City, UtahAges Up to 1 hour - NCT07240038Recruiting
Reducing breathing problems in NICU babies on ventilators
This study is testing a way to reduce the chance of a certain breathing problem (called NAV) in babies who need a breathing machine in the NICU. If your baby has been on the machine for two days or more, they may be able to join.
A Coruña, A CoruñaAges birth–6 months - NCT05197621Recruiting
Study how COVID-19 affects pregnancy and newborn outcomes
This study looks at how COVID-19 and COVID vaccination during pregnancy may affect mothers and newborns. Your team will collect health information around delivery to understand what outcomes are most common.
Baltimore, MarylandAges 14–55 - NCT06145841Recruiting
Gene test to guide infection treatment in AIDS
This study is for people with HIV/AIDS who develop severe pneumonia or septic shock. It uses a special genetic test (metagenomic next-generation sequencing) to find the exact germ causing the infection so doctors can choose the right antibiotic.
Guangzhou, GuangdongAges 18–65 - NCT07275606RecruitingPhase 1/Phase 2
Testing HIV prevention medicine cabotegravir in newborns
This study tests a long-acting injectable HIV prevention medicine called cabotegravir in newborn babies who were exposed to HIV. The goal is to see if it can help protect them from getting HIV.
Parow ValleyAges Up to 1 week
Hear when a new Neonatal Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for neonatal infection?
- Yes. Clin2 currently lists 28 recruiting neonatal infection studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a neonatal infection trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a neonatal infection trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.